Clinical Trial Update: ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children [Phase 3]

View source ↗

Summary

Sanofi reports completion of a Phase 3 trial evaluating Enterogermina (Bacillus clausii) for the management of gastroenteritis-related diarrhea in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis

Drugs mentioned

• Enterogermina (Bacillus clausii)

Snippet

Sponsor: Sanofi | Conditions: Gastroenteritis | Phase 3 | Status: COMPLETED